English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Financial Funds & Equities
Tiger Brokers adds ASX to its Online Trading & Mobile App
Sep 18, 2020 13:30 HKT
Tiger Brokers Singapore Adds ASX to its Online and Mobile Trading Apps, Addressing Demand from Investors
Sep 17, 2020 15:00 HKT
HKTDC Export Index 3Q20: Exporter confidence rises for second consecutive quarter
Sep 14, 2020 18:00 HKT
Greenbriar Capital Corp Reports $2,771,759 or $0.12 per Share of Net Income in Q2 2020
Sep 03, 2020 04:00 HKT
Compagnie Financiere Tradition SA Acquires 100% of OM Wholesale in New Zealand
Sep 02, 2020 08:00 HKT
Singapore's Elite Partners Acquires Warehouse in Poland for over EUR30 Million (S$48.6 Million) from Subsidiary of Sovereign Fund GIC
Aug 31, 2020 11:00 HKT
禹洲集团(01628.HK)上半年收入按年升20.4%至逾140亿人民币 派发中期息每股12港仙
Aug 25, 2020 13:33 HKT
禹洲集團(01628.HK)上半年收入按年升20.4%至逾140億人民幣 派發中期息每股12港仙
Aug 25, 2020 13:32 HKT
Nathan's Famous Partners With UAE Based Mezzan Group to Manufacture Halal Hot Dogs
Aug 15, 2020 13:00 HKT
Inaugural 'Standard Chartered GBA Business Confidence Index'
Jul 23, 2020 18:00 HKT
Greenbriar Comments on Recent Controversy on Social Media
Jul 23, 2020 13:00 HKT
Episode Six Secures $7 Million to Accelerate Global Growth as Demand for Digital Transformation Increases
Jul 21, 2020 21:00 HKT
伯克哈德·迪克教授正式加入德视佳眼科国际医学顾问委员会
Jul 15, 2020 14:23 HKT
伯克哈德·迪克教授正式加入德視佳眼科國際醫學顧問委員會
Jul 15, 2020 14:22 HKT
Dr. Burkhard Dick Joins the EuroEyes International Medical Advisory Board
Jul 15, 2020 14:21 HKT
Greenbriar Executes a Master Sales and Marketing Agreement with Keller Willams - Paul Morris Forward Living Inc
Jul 13, 2020 06:00 HKT
AIM ImmunoTech(AIM)与Roswell Park综合癌症中心签署临床试验协议,支持Ampligen联合干扰素Alfa-2b治疗感染COVID-19的癌症患者的1/2期临床试验
Jul 10, 2020 08:00 HKT
AIM ImmunoTech(AIM)與Roswell Park綜合癌症中心簽署臨床試驗協議,支持Ampligen聯合干擾素Alfa-2b治療感染COVID-19的癌症患者的1/2期臨床試驗
Jul 10, 2020 08:00 HKT
Advanced "YES UA" Mobile APP supports instant verification with New Smart ID Cards
Jul 09, 2020 06:00 HKT
AIM ImmunoTech(AIM)与日本国立传染病研究所及全球领先的制药公司Shionogi签署传质和研究协议,以测试扩增素是否可作为COVID-19的潜在疫苗佐剂
Jul 08, 2020 08:00 HKT
Next >>
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: